ATL 1102
Product Specifications
UNSPSC Description
ATL 1102 is a novel second-generation antisense oligonucleotide to CD49d mRNA
Target Antigen
Integrin
Type
Oligonucleotides
Related Pathways
Cytoskeleton
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/atl-1102.html
Solubility
10 mM in H2O
Smiles
[ATL 1102]
References & Citations
[1]Duchartre Y, Bachl S, Kim HN, et al. Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies. PLoS One. 2017;12(11):e0187684. |[2]Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G; ATL1102 Study Group. CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS [published correction appears in Neurology. 2015 Jan 6;84(1):105]. Neurology. 2014;83(20):1780-1788.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-153481/ATL-1102-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-153481/
Clinical Information
Phase 2
CAS Number
350263-41-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
